Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis.

Open heart

Morris DA, Ma XX, Belyavskiy E, Aravind Kumar R, Kropf M, Kraft R, Frydas A, Osmanoglou E, Marquez E, Donal E, Edelmann F, Tschöpe C, Pieske B, Pieske-Kraigher E.
PMID: 29018535
Open Heart. 2017 Sep 25;4(2):e000630. doi: 10.1136/openhrt-2017-000630. eCollection 2017.

BACKGROUND: The purpose of this meta-analysis was to confirm if the global longitudinal systolic function of the left ventricle (LV) is altered in patients with heart failure with preserved ejection fraction (HFpEF).METHODS: We searched in different databases (Medline, Embase...

Cite
Morris DA, Ma XX, Belyavskiy E, et al. Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis. Open Heart. 2017;4(2):e000630doi: 10.1136/openhrt-2017-000630.
Morris, D. A., Ma, X. X., Belyavskiy, E., Aravind Kumar, R., Kropf, M., Kraft, R., Frydas, A., Osmanoglou, E., Marquez, E., Donal, E., Edelmann, F., Tschöpe, C., Pieske, B., & Pieske-Kraigher, E. (2017). Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis. Open heart, 4(2), e000630. https://doi.org/10.1136/openhrt-2017-000630
Morris, Daniel Armando, et al. "Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis." Open heart vol. 4,2 (2017): e000630. doi: https://doi.org/10.1136/openhrt-2017-000630
Morris DA, Ma XX, Belyavskiy E, Aravind Kumar R, Kropf M, Kraft R, Frydas A, Osmanoglou E, Marquez E, Donal E, Edelmann F, Tschöpe C, Pieske B, Pieske-Kraigher E. Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis. Open Heart. 2017 Sep 25;4(2):e000630. doi: 10.1136/openhrt-2017-000630. eCollection 2017. PMID: 29018535; PMCID: PMC5623331.
Copy Download .nbib Format: NLM
Somatic .

Journal of the Endocrine Society

Tatsi C, Faucz FR, Blavakis E, Carneiro BA, Lyssikatos C, Belyavskaya E, Quezado M, Stratakis CA.
PMID: 31286102
J Endocr Soc. 2019 May 10;3(7):1375-1382. doi: 10.1210/js.2019-00022. eCollection 2019 Jul 01.

Large cell calcifying Sertoli cell tumors (LCCSCTs) are rare testicular tumors, representing

Cite
Tatsi C, Faucz FR, Blavakis E, et al. Somatic . J Endocr Soc. 2019;3(7):1375-1382doi: 10.1210/js.2019-00022.
Tatsi, C., Faucz, F. R., Blavakis, E., Carneiro, B. A., Lyssikatos, C., Belyavskaya, E., Quezado, M., & Stratakis, C. A. (2019). Somatic . Journal of the Endocrine Society, 3(7), 1375-1382. https://doi.org/10.1210/js.2019-00022
Tatsi, Christina, et al. "Somatic ." Journal of the Endocrine Society vol. 3,7 (2019): 1375-1382. doi: https://doi.org/10.1210/js.2019-00022
Tatsi C, Faucz FR, Blavakis E, Carneiro BA, Lyssikatos C, Belyavskaya E, Quezado M, Stratakis CA. Somatic . J Endocr Soc. 2019 May 10;3(7):1375-1382. doi: 10.1210/js.2019-00022. eCollection 2019 Jul 01. PMID: 31286102; PMCID: PMC6608558.
Copy Download .nbib Format: NLM
Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening.

Nature communications

Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, Coffin A, Davie CP, Deng H, Deng J, Ding Y, Dodson JW, Fosbenner DT, Gao EN, Graham TL, Graybill TL, Ingraham K, Johnson WP, King BW, Kwiatkowski CR, Lelièvre J, Li Y, Liu X, Lu Q, Lehr R, Mendoza-Losana A, Martin J, McCloskey L, McCormick P, O'Keefe HP, O'Keeffe T, Pao C, Phelps CB, Qi H, Rafferty K, Scavello GS, Steiginga MS, Sundersingh FS, Sweitzer SM, Szewczuk LM, Taylor A, Fern Toh M, Wang J, Wang M, Wilkins DJ, Xia B, Yao G, Zhang J, Zhou J, Donahue CP, Messer JA, Holmes D, Arico-Muendel CC, Pope AJ, Gross JW, Evindar G.
PMID: 30004092
Nat Commun. 2018 Jul 13;9:16227. doi: 10.1038/ncomms16227.

This corrects the article DOI: 10.1038/ncomms16081.

Cite
Machutta CA, Kollmann CS, Lind KE, et al. Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nat Commun. 2018;9:16227doi: 10.1038/ncomms16227.
Machutta, C. A., Kollmann, C. S., Lind, K. E., Bai, X., Chan, P. F., Huang, J., Ballell, L., Belyanskaya, S., Besra, G. S., Barros-Aguirre, D., Bates, R. H., Centrella, P. A., Chang, S. S., Chai, J., Choudhry, A. E., Coffin, A., Davie, C. P., Deng, H., Deng, J., Ding, Y., Dodson, J. W., Fosbenner, D. T., Gao, E. N., Graham, T. L., Graybill, T. L., Ingraham, K., Johnson, W. P., King, B. W., Kwiatkowski, C. R., Lelièvre, J., Li, Y., Liu, X., Lu, Q., Lehr, R., Mendoza-Losana, A., Martin, J., McCloskey, L., McCormick, P., O'Keefe, H. P., O'Keeffe, T., Pao, C., Phelps, C. B., Qi, H., Rafferty, K., Scavello, G. S., Steiginga, M. S., Sundersingh, F. S., Sweitzer, S. M., Szewczuk, L. M., Taylor, A., Fern Toh, M., Wang, J., Wang, M., Wilkins, D. J., Xia, B., Yao, G., Zhang, J., Zhou, J., Donahue, C. P., Messer, J. A., Holmes, D., Arico-Muendel, C. C., Pope, A. J., Gross, J. W., & Evindar, G. (2018). Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nature communications, 916227. https://doi.org/10.1038/ncomms16227
Machutta, Carl A, et al. "Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening." Nature communications vol. 9 (2018): 16227. doi: https://doi.org/10.1038/ncomms16227
Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, Coffin A, Davie CP, Deng H, Deng J, Ding Y, Dodson JW, Fosbenner DT, Gao EN, Graham TL, Graybill TL, Ingraham K, Johnson WP, King BW, Kwiatkowski CR, Lelièvre J, Li Y, Liu X, Lu Q, Lehr R, Mendoza-Losana A, Martin J, McCloskey L, McCormick P, O'Keefe HP, O'Keeffe T, Pao C, Phelps CB, Qi H, Rafferty K, Scavello GS, Steiginga MS, Sundersingh FS, Sweitzer SM, Szewczuk LM, Taylor A, Fern Toh M, Wang J, Wang M, Wilkins DJ, Xia B, Yao G, Zhang J, Zhou J, Donahue CP, Messer JA, Holmes D, Arico-Muendel CC, Pope AJ, Gross JW, Evindar G. Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nat Commun. 2018 Jul 13;9:16227. doi: 10.1038/ncomms16227. PMID: 30004092; PMCID: PMC6054520.
Copy Download .nbib Format: NLM
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Thrombosis and haemostasis

Liesner RJ, Abraham A, Altisent C, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jimenez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pavlova A, Pollio B, Sigaud M, Vdovin V, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ.
PMID: 33581698
Thromb Haemost. 2021 Nov;121(11):1400-1408. doi: 10.1055/s-0040-1722623. Epub 2021 Feb 13.

INTRODUCTION:  FVIII inhibitor development is the most serious contemporary treatment complication in haemophilia A, particularly in previously untreated patients (PUPs). No inhibitors developed in clinical trials in previously treated patients treated with simoctocog alfa (Nuwiq), a fourth-generation recombinant FVIII...

Cite
Liesner RJ, Abraham A, Altisent C, et al. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study. Thromb Haemost. 2021;121(11):1400-1408doi: 10.1055/s-0040-1722623.
Liesner, R. J., Abraham, A., Altisent, C., Belletrutti, M. J., Carcao, M., Carvalho, M., Chambost, H., Chan, A. K. C., Dubey, L., Ducore, J., Gattens, M., Gresele, P., Gruel, Y., Guillet, B., Jimenez-Yuste, V., Kitanovski, L., Klukowska, A., Lohade, S., Mancuso, M. E., Oldenburg, J., Pavlova, A., Pollio, B., Sigaud, M., Vdovin, V., Vilchevska, K., Wu, J. K. M., Jansen, M., Belyanskaya, L., Walter, O., Knaub, S., & Neufeld, E. J. (2021). Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study. Thrombosis and haemostasis, 121(11), 1400-1408. https://doi.org/10.1055/s-0040-1722623
Liesner, Ri J, et al. "Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study." Thrombosis and haemostasis vol. 121,11 (2021): 1400-1408. doi: https://doi.org/10.1055/s-0040-1722623
Liesner RJ, Abraham A, Altisent C, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jimenez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pavlova A, Pollio B, Sigaud M, Vdovin V, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study. Thromb Haemost. 2021 Nov;121(11):1400-1408. doi: 10.1055/s-0040-1722623. Epub 2021 Feb 13. PMID: 33581698; PMCID: PMC8570909.
Copy Download .nbib Format: NLM
Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions.

JAMA internal medicine

Belyavskaya J, deSouza IS.
PMID: 34842898
JAMA Intern Med. 2021 Nov 29; doi: 10.1001/jamainternmed.2021.6887. Epub 2021 Nov 29.

No abstract available.

Cite
Belyavskaya J, deSouza IS. Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA Intern Med. 2021;doi: 10.1001/jamainternmed.2021.6887.
Belyavskaya, J., & deSouza, I. S. (2021). Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA internal medicine, . https://doi.org/10.1001/jamainternmed.2021.6887
Belyavskaya, Jane, and deSouza, Ian S. "Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions." JAMA internal medicine vol. (2021). doi: https://doi.org/10.1001/jamainternmed.2021.6887
Belyavskaya J, deSouza IS. Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA Intern Med. 2021 Nov 29; doi: 10.1001/jamainternmed.2021.6887. Epub 2021 Nov 29. PMID: 34842898.
Copy Download .nbib Format: NLM
Aortic pulse wave velocity in children with Cushing syndrome: A window into a marker of early cardiovascular disease.

Endocrinology, diabetes & metabolism

Blain H, Sinaii N, Zeltser D, Lyssikatos C, Belyavskaya E, Keil M, Bluemke DA, Stratakis C, Bandettini WP, Lodish M.
PMID: 31008362
Endocrinol Diabetes Metab. 2019 Jan 15;2(2):e00054. doi: 10.1002/edm2.54. eCollection 2019 Apr.

OBJECTIVE: To investigate early signs of cardiovascular arterial remodelling in paediatric patients with Cushing syndrome (CS) in comparison with normative values from healthy children.STUDY DESIGN: The metrics used to assess cardiac health were from thoracic aorta and carotid MRI....

Cite
Blain H, Sinaii N, Zeltser D, et al. Aortic pulse wave velocity in children with Cushing syndrome: A window into a marker of early cardiovascular disease. Endocrinol Diabetes Metab. 2019;2(2):e00054doi: 10.1002/edm2.54.
Blain, H., Sinaii, N., Zeltser, D., Lyssikatos, C., Belyavskaya, E., Keil, M., Bluemke, D. A., Stratakis, C., Bandettini, W. P., & Lodish, M. (2019). Aortic pulse wave velocity in children with Cushing syndrome: A window into a marker of early cardiovascular disease. Endocrinology, diabetes & metabolism, 2(2), e00054. https://doi.org/10.1002/edm2.54
Blain, Hailey, et al. "Aortic pulse wave velocity in children with Cushing syndrome: A window into a marker of early cardiovascular disease." Endocrinology, diabetes & metabolism vol. 2,2 (2019): e00054. doi: https://doi.org/10.1002/edm2.54
Blain H, Sinaii N, Zeltser D, Lyssikatos C, Belyavskaya E, Keil M, Bluemke DA, Stratakis C, Bandettini WP, Lodish M. Aortic pulse wave velocity in children with Cushing syndrome: A window into a marker of early cardiovascular disease. Endocrinol Diabetes Metab. 2019 Jan 15;2(2):e00054. doi: 10.1002/edm2.54. eCollection 2019 Apr. PMID: 31008362; PMCID: PMC6458483.
Copy Download .nbib Format: NLM
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations.

Therapeutics and clinical risk management

Dzhioeva O, Belyavskiy E.
PMID: 32904123
Ther Clin Risk Manag. 2020 Aug 21;16:769-785. doi: 10.2147/TCRM.S207117. eCollection 2020.

Heart failure with preserved ejection fraction (HFpEF) is a major global public health problem. Diagnosis of HFpEF is still challenging and built based on the comprehensive echocardiographic analysis. Currently, there are no universally accepted therapies that alter the clinical...

Cite
Dzhioeva O, Belyavskiy E. Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. Ther Clin Risk Manag. 2020;16:769-785doi: 10.2147/TCRM.S207117.
Dzhioeva, O., & Belyavskiy, E. (2020). Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. Therapeutics and clinical risk management, 16769-785. https://doi.org/10.2147/TCRM.S207117
Dzhioeva, Olga, and Belyavskiy, Evgeny. "Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations." Therapeutics and clinical risk management vol. 16 (2020): 769-785. doi: https://doi.org/10.2147/TCRM.S207117
Dzhioeva O, Belyavskiy E. Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. Ther Clin Risk Manag. 2020 Aug 21;16:769-785. doi: 10.2147/TCRM.S207117. eCollection 2020. PMID: 32904123; PMCID: PMC7450524.
Copy Download .nbib Format: NLM
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies.

Journal of clinical medicine

Tadic M, Cuspidi C, Plein S, Belyavskiy E, Heinzel F, Galderisi M.
PMID: 31167429
J Clin Med. 2019 Jun 04;8(6). doi: 10.3390/jcm8060792.

Heart failure with preserved ejection fraction (HFpEF) represents the most frequent form of heart failure in women, with almost two-fold higher prevalence than in men. Studies have revealed sex-specific HFpEF pathophysiology, and suggested the possibility of a sex-specific therapeutic...

Cite
Tadic M, Cuspidi C, Plein S, et al. Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies. J Clin Med. 2019;8(6)doi: 10.3390/jcm8060792.
Tadic, M., Cuspidi, C., Plein, S., Belyavskiy, E., Heinzel, F., & Galderisi, M. (2019). Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies. Journal of clinical medicine, 8(6), . https://doi.org/10.3390/jcm8060792
Tadic, Marijana, et al. "Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies." Journal of clinical medicine vol. 8,6 (2019). doi: https://doi.org/10.3390/jcm8060792
Tadic M, Cuspidi C, Plein S, Belyavskiy E, Heinzel F, Galderisi M. Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies. J Clin Med. 2019 Jun 04;8(6). doi: 10.3390/jcm8060792. PMID: 31167429; PMCID: PMC6617502.
Copy Download .nbib Format: NLM
Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia.

HemaSphere

Stoma I, Karpov I, Uss A, Krivenko S, Iskrov I, Milanovich N, Vlasenkova S, Lendina I, Belyavskaya K, Charniak V.
PMID: 31723809
Hemasphere. 2019 Jan 08;3(1):e170. doi: 10.1097/HS9.0000000000000170. eCollection 2019 Feb.

No abstract available.

Cite
Stoma I, Karpov I, Uss A, et al. Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia. Hemasphere. 2019;3(1):e170doi: 10.1097/HS9.0000000000000170.
Stoma, I., Karpov, I., Uss, A., Krivenko, S., Iskrov, I., Milanovich, N., Vlasenkova, S., Lendina, I., Belyavskaya, K., & Charniak, V. (2019). Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia. HemaSphere, 3(1), e170. https://doi.org/10.1097/HS9.0000000000000170
Stoma, Igor, et al. "Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia." HemaSphere vol. 3,1 (2019): e170. doi: https://doi.org/10.1097/HS9.0000000000000170
Stoma I, Karpov I, Uss A, Krivenko S, Iskrov I, Milanovich N, Vlasenkova S, Lendina I, Belyavskaya K, Charniak V. Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia. Hemasphere. 2019 Jan 08;3(1):e170. doi: 10.1097/HS9.0000000000000170. eCollection 2019 Feb. PMID: 31723809; PMCID: PMC6745942.
Copy Download .nbib Format: NLM
RF magnetron-sputtered coatings deposited from biphasic calcium phosphate targets for biomedical implant applications.

Bioactive materials

Prosolov KA, Popova KS, Belyavskaya OA, Rau JV, Gross KA, Ubelis A, Sharkeev YP.
PMID: 29744427
Bioact Mater. 2017 Jul 31;2(3):170-176. doi: 10.1016/j.bioactmat.2017.07.003. eCollection 2017 Sep.

Bioactive calcium phosphate coatings were deposited by radio-frequency magnetron sputtering from biphasic targets of hydroxyapatite and tricalcium phosphate, sintered at different mass % ratios. According to Raman scattering and X-ray diffraction data, the deposited hydroxyapatite coatings have a disordered...

Cite
Prosolov KA, Popova KS, Belyavskaya OA, et al. RF magnetron-sputtered coatings deposited from biphasic calcium phosphate targets for biomedical implant applications. Bioact Mater. 2017;2(3):170-176doi: 10.1016/j.bioactmat.2017.07.003.
Prosolov, K. A., Popova, K. S., Belyavskaya, O. A., Rau, J. V., Gross, K. A., Ubelis, A., & Sharkeev, Y. P. (2017). RF magnetron-sputtered coatings deposited from biphasic calcium phosphate targets for biomedical implant applications. Bioactive materials, 2(3), 170-176. https://doi.org/10.1016/j.bioactmat.2017.07.003
Prosolov, K A, et al. "RF magnetron-sputtered coatings deposited from biphasic calcium phosphate targets for biomedical implant applications." Bioactive materials vol. 2,3 (2017): 170-176. doi: https://doi.org/10.1016/j.bioactmat.2017.07.003
Prosolov KA, Popova KS, Belyavskaya OA, Rau JV, Gross KA, Ubelis A, Sharkeev YP. RF magnetron-sputtered coatings deposited from biphasic calcium phosphate targets for biomedical implant applications. Bioact Mater. 2017 Jul 31;2(3):170-176. doi: 10.1016/j.bioactmat.2017.07.003. eCollection 2017 Sep. PMID: 29744427; PMCID: PMC5935179.
Copy Download .nbib Format: NLM
Case Report: Assessing the Position of Pacemaker Leads .

Frontiers in cardiovascular medicine

Deichl AS, Lacour P, Belyavskiy E, Pieske B, Pieske-Kraigher E, Blaschke F, Schneider M.
PMID: 34150875
Front Cardiovasc Med. 2021 Jun 04;8:697052. doi: 10.3389/fcvm.2021.697052. eCollection 2021.

There is an association between presence of cardiac implantable electronic devices (CIED) and development of tricuspid regurgitation (TR). Mechanisms proposed to explain CIED-induced TR can be classified as implantation-related, lead-related, and pacing-related. Lead-related TR results from the direct interaction...

Cite
Deichl AS, Lacour P, Belyavskiy E, et al. Case Report: Assessing the Position of Pacemaker Leads . Front Cardiovasc Med. 2021;8:697052doi: 10.3389/fcvm.2021.697052.
Deichl, A. S., Lacour, P., Belyavskiy, E., Pieske, B., Pieske-Kraigher, E., Blaschke, F., & Schneider, M. (2021). Case Report: Assessing the Position of Pacemaker Leads . Frontiers in cardiovascular medicine, 8697052. https://doi.org/10.3389/fcvm.2021.697052
Deichl, Andrea Simone, et al. "Case Report: Assessing the Position of Pacemaker Leads ." Frontiers in cardiovascular medicine vol. 8 (2021): 697052. doi: https://doi.org/10.3389/fcvm.2021.697052
Deichl AS, Lacour P, Belyavskiy E, Pieske B, Pieske-Kraigher E, Blaschke F, Schneider M. Case Report: Assessing the Position of Pacemaker Leads . Front Cardiovasc Med. 2021 Jun 04;8:697052. doi: 10.3389/fcvm.2021.697052. eCollection 2021. PMID: 34150875; PMCID: PMC8213207.
Copy Download .nbib Format: NLM
Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions.

JAMA internal medicine

Belyavskaya J, deSouza IS.
PMID: 34842898
JAMA Intern Med. 2022 Jan 01;182(1):74-75. doi: 10.1001/jamainternmed.2021.6887.

No abstract available.

Cite
Belyavskaya J, deSouza IS. Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA Intern Med. 2022;182(1):74-75doi: 10.1001/jamainternmed.2021.6887.
Belyavskaya, J., & deSouza, I. S. (2022). Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA internal medicine, 182(1), 74-75. https://doi.org/10.1001/jamainternmed.2021.6887
Belyavskaya, Jane, and deSouza, Ian S. "Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions." JAMA internal medicine vol. 182,1 (2022): 74-75. doi: https://doi.org/10.1001/jamainternmed.2021.6887
Belyavskaya J, deSouza IS. Not All Electrocardiographic ST-Elevations Are Acute Coronary Occlusions. JAMA Intern Med. 2022 Jan 01;182(1):74-75. doi: 10.1001/jamainternmed.2021.6887. PMID: 34842898.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries